NCT02584244View on ClinicalTrials.gov

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 4, 2016

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2026

Conditions
Colorectal CancerPancreatic CancerEsophageal CancerGastric Cancer
Interventions
DRUG

LUM015

DEVICE

LUM 2.6 Imaging Device

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

Lumicell, Inc.
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Lumicell, Inc.

INDUSTRY